Navigation Links
Proper Validation of Generic Drugs Could Save Millions of AIDS Patients

Increasing criticism is faced by AIDS generic drugs usage to treat HIV infections, due to non-compliance with clinical and laboratory procedures and data handling. Recently, the use of Anti-HIV single dose drug // Nevirapine which is used for the prevention of mother to child transmission is very much questioned of its effect.

Though Generic drugs is used by the large population of people during epidemics, due to its low cost formulations, which is useful for the treatment of millions of people as a life saving drug, there are evidence that generic drugs are as safe and as effective as branded drugs. In Brazil massive use of generic drug treatment as reduced HIV mortality.

Some critics point out that generic drugs are not monitored and tested properly as branded drugs produced by global pharmaceutical companies and comment generic drugs as “dubious”, “cheap”, and “deadly”, though it is commented by some critics in reality generic drugs offer the most affordable and best treatment for infected people in developing countries.

It is the fundamental right of the patient to know what drug they are taking and how effective and safe the drug is, and the patient should be aware that unsafe drugs could cause drug resistance and new strains of virus could emerge. Generic drug manufacturers are mostly from the Asian countries, there are 27 manufacturers in Asian countries, mostly they are produced for domestic uses and some drugs are exported, the countries mostly manufacturing generic drugs are China, India, and Thailand. The manufacturing companies are wholly or partly owned by the government enterprises, and these companies can simply sell drugs to their own government, fostering an intimacy between manufacturers and governments.

A system of drug monitoring of generic drugs is required, by which a network of clinical laboratory is to be linked to the generic drugs for its testing and validation before marketing of the product simi lar to the FDA or WHO and the monitoring should be a continuous process so that he quality of the drug produced should be monitored to find if there is fluctuation over time without vigilant testing. By this way if the generic drug produced is maintained in a standard to that of branded drugs, the amount of investment which is spent on the branded drugs would be saved enormously, and if proper system is maintained in monitoring and validation of generic drugs it would be very much useful for patients in developing and underdeveloped countries as it would offer an affordable and effective treatment to the affected patients, as the HIV-infected population is continuously climbing and it is estimated that 6 million HIV patients will die without immediate access to antiretroviral drugs.

Source: The Lanet.
'"/>




Related medicine news :

1. Compounds Found In The Vegetable Broccoli Could Have Anti-Cancer Properties
2. Geriatric Patients With Chronic Kidney Disease May Not Be Treated Properly
3. Stem Cells, Tumor Cells Share Similar Properties: Scope For Treatment and Prevention?
4. Fruits And Vegetables Have Arthritis Risk Reducing Property
5. Proper Treatment of Hypothyroidism Found To Prevent Heart Diseases
6. Colon Cancer Patients Not Receiving Proper Treatment
7. Proper Diet Can Counter Macular Degeneration
8. Scots Do Not Have Access To Proper Dental Care
9. Risk Of Stroke Can Be Lessened By Proper Diet
10. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
11. Anticancer Properties of Vitamin D Could Be Separated From Other Functions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines from the ... studies, the Center for Disease Control ( CDC ) and Infectious Diseases Society of ... Liegner, M.D. has compiled into a single volume a compelling argument that the disease ...
(Date:2/27/2017)... ... February 27, 2017 , ... Sunshine Coast ... in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the ... Mackenzie Alsager, showcases the Centre's commitment to innovation in drug rehab and alcohol ...
(Date:2/27/2017)... ... February 27, 2017 , ... Silicon Valley Hair Institute, ... announce an upgrade to the company's Yelp listing. Bay Area residents struggling from ... diverse as Platelet Rich Plasma (PRP) therapy, hair transplantation techniques such as Follicular ...
(Date:2/26/2017)... MICHIGAN (PRWEB) , ... February 25, 2017 , ... The ... Kim Jong-un, heightened awareness and concern over nerve agents and the deadly use of ... the human nervous system and how even small doses can be lethal. , Jay ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... lab became the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der ... , ISO/IEC 17025:2005 is the globally recognised standard that sets out requirements for ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 23, 2017  The particle counters market is ... from USD 275.9 million in 2016, at a ... report: http://www.reportlinker.com/p04718602-summary/view-report.html The growing ... R&D, and growth in manufacturing industries in emerging ... for particle counters. On the other hand, technical ...
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)... YORK , Feb. 23, 2017  Genesis Healthcare ... Company. The announcement was made by Bill Monast ... David Hartley and Nathan Feltman , executives ... Genesis Healthcare Services, LLC. This acquisition ... largest provider of technology enabled durable medical equipment (DME) ...
Breaking Medicine Technology: